Pharma

Data Analytics: Redefining Healthcare Management

Big data is now slowly revolutionizing global healthcare management. Pharma companies have been gathering years of clinical research data into medical databases, while providers and payers have been digitalizing their patient records.

Single-Use Bioreactors: An Established Addition to Biotechnology Manufacturing

Over the past few years, the demand for biopharmaceutical manufacturing outsourcing has increased. This is to create and maintain market access of biologics through scalability and flexibility of their operations. Innovation and increasing R&D investment in manufacturing technology is driving a change to improve their process and provide high-quality products.

Nearshoring – Paving the Way for Effective Pharma Manufacturing

Strategizing in pharma often means weighing out the advantages, pitfalls and cost of various alternatives.

How Procurement Can Help Pharma Companies Boost Savings

Pharma companies are racing against time to meet the deadline for serialization compliance for drugs, as mandated by regulatory authorities of over 40 countries across the world. As of July 2017, it was estimated that 30 percent of companies are not prepared for serialization, with small and midsized companies accounting for the major chunk. Even though U.S.

Adoption of Internet of Things in Pharma Manufacturing

Pharmaceutical companies are adopting Internet of Things (IoT) technologies in their manufacturing plants to achieve optimization and improve efficiency of their machines and processes. Earlier techniques for synchronization of data was time-consuming and highly susceptible to human error. Different data formats used in a manufacturing plant for different processes made data access and its interpretation a barrier for effective communication. IoT technologies facilitates standardization within a facility by connecting equipment, networks, and systems to share information across the plant floor.

Sustained Decrease in Medical Polymer Prices: Did You Realize Million Dollars In Savings?

Sustained depression in crude oil prices, from $100 per barrel in 2014 to the current level of $50 per barrel, has brought the prices of derived polymers such as Polypropylene (PP), Polyethylene (PE) and others down by an average of 20 to 30 percent.

Evolution of 3D Printing in Healthcare Industry

The impact of 3D printing has been far flung, with several industries waking up to the true potential of this innovative technology. But if there is one industry where this technology has been at its transformative best, it is the healthcare industry. At a time when healthcare costs are rapidly spiraling, 3D printing has emerged as a cost-effective and widely accessible technology option.

Technology Transfer in the Pharmaceutical Industry for Setting Up Operations in New Markets

Pharmaceutical companies are increasingly adopting technology transfer strategies to gain a foothold in the Russian, Chinese and Brazilian markets, where there are high barriers to entry. Technology transfer helps companies increase cost competitiveness by leveraging the low manufacturing costs in those regions. The traditional model of setting up subsidiaries is complicated, time consuming and capital intensive. Additionally, these countries have strict regulations on importing drugs and low FDI investments, as they seek to protect their local companies and production.

Innovations in Healthcare by Major Technology Players

The healthcare industry is gaining increasing attention from major technology companies like Alphabet, Apple and IBM. By leveraging their expertise in domains like artificial intelligence and machine learning, they help pharma and medical device companies analyze big data generated in the healthcare value chain. This includes data collected from clinical trials, electronic health records (EHR), wearables and other sources. Companies can then use the analysis to understand patient behavior, reduce inefficiencies, improve current products and lifecycles, and develop more innovative products.

Artificial Intelligence: A Step Forward in Clinical Trials

By 2021, the global use of artificial intelligence (AI) in healthcare is expected to achieve a CAGR of 42 percent – a rapid adoption rate. The marketplace needs innovation to fast-track development of new compounds, evaluate their efficacy and safety, and reduce failure rates. Artificial intelligence (AI) shows great potential to address these challenges. Advanced AI systems enabled with deep learning can help accelerate drug discovery and reduce the number of failures in clinical trials. GSK recently announced a strategic drug discovery collaboration with Exscientia that will help discover small molecules through Exscientia’s AI-enabled platform. Moreover, Genentech, along with GNS Healthcare, aims to use artificial intelligence to convert high volumes of cancer patient data into computer models that can be used to identify new targets for cancer therapy.

© Copyright GEP 2017. All rights reserved.